Mohankumar Kumarasamypet M, Perry Jo K, Kannan Nagarajan, Kohno Kimitoshi, Gluckman Peter D, Emerald B Starling, Lobie Peter E
The Liggins Institute and National Research Centre for Growth and Development, University of Auckland, Auckland, New Zealand.
Endocrinology. 2008 May;149(5):2219-29. doi: 10.1210/en.2007-1320. Epub 2008 Feb 14.
We have previously demonstrated that the p44/42 MAPK pathway is one pathway involved in homeobox (HOX) A1-stimulated oncogenesis. However, inhibition of MAPK kinase 1 does not completely prevent HOXA1-stimulated oncogenic transformation, suggesting the involvement of additional signal transduction pathways. Here, we report that forced expression of HOXA1 in immortalized human mammary epithelial cells significantly increased levels of signal transducer and activator of transcription (STAT) 3, 5A, and 5B mRNA by transcriptional up-regulation. The protein levels of STAT3 and 5B, but not STAT5A, and protein phosphorylation levels of STAT3 and 5B were significantly increased by forced expression of HOXA1. Forced expression of STAT3 or STAT5B was sufficient to transform oncogenically an immortalized human mammary epithelial cell line. Accordingly, inhibition of STAT3 or STAT5B activity with dominant negative STAT3 or STAT5B abrogated the ability of HOXA1 to stimulate cell proliferation, survival, oncogenic transformation, and generation of large disorganized multiacinar structures in three-dimensional culture. These results suggest that HOXA1 partially mediates oncogenic transformation of the immortalized human mammary epithelial cell through modulation of the STAT3 and STAT5B pathways.
我们之前已经证明,p44/42丝裂原活化蛋白激酶(MAPK)信号通路是参与同源框(HOX)A1刺激的肿瘤发生的一条信号通路。然而,抑制MAPK激酶1并不能完全阻止HOXA1刺激的致癌转化,这表明还存在其他信号转导通路参与其中。在此,我们报告,在永生化的人乳腺上皮细胞中强制表达HOXA1,通过转录上调显著增加了信号转导及转录激活因子(STAT)3、5A和5B的mRNA水平。HOXA1的强制表达显著增加了STAT3和5B的蛋白水平(但不包括STAT5A)以及STAT3和5B的蛋白磷酸化水平。强制表达STAT3或STAT5B足以使永生化的人乳腺上皮细胞系发生致癌转化。因此,用显性负性STAT3或STAT5B抑制STAT3或STAT5B的活性,可消除HOXA1在三维培养中刺激细胞增殖、存活、致癌转化以及形成大的无序多腺泡结构的能力。这些结果表明,HOXA1通过调节STAT3和STAT5B信号通路部分介导了永生化人乳腺上皮细胞的致癌转化。